{
    "clinical_study": {
        "@rank": "153093", 
        "acronym": "MAPs", 
        "arm_group": {
            "arm_group_label": "phrenic nerve stimulation", 
            "arm_group_type": "Experimental", 
            "description": "intravenously stimulating the phrenic nerve"
        }, 
        "brief_summary": {
            "textblock": "The Mapping for Transvenous Phrenic Nerve Stimulation Study (MAPS) is being conducted to\n      evaluate the feasibility of transvascular stimulation of phrenic nerves via an EP catheter\n      advanced into the great veins."
        }, 
        "brief_title": "Mapping for Acute Transvenous Phrenic Nerve Stimulation Study", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Purpose The Mapping for Transvenous Phrenic Nerve Stimulation Study (MAPS) is being\n      conducted to evaluate the feasibility of transvascular stimulation of phrenic nerves via an\n      EP catheter advanced into the great veins.\n\n      Study Design This is a prospective, non-randomized, acute feasibility study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects older than 18 years of age\n\n          -  Subject is undergoing a cardiac catheterization involving right heart catheterization\n             and/or EP procedures and/or device implant.\n\n          -  Subjects willing and able to give informed consent\n\n        Exclusion Criteria:\n\n          -  Subject with a previously implanted transvenous lead, which is still present in the\n             veins under study.\n\n          -  Subject with evidence of phrenic nerve palsy.\n\n          -  Subject with chronic obstructive pulmonary disease.\n\n          -  Subject with a spinal cord stimulator.\n\n          -  Subject needs to receive drugs that might interfere with patient perception.\n\n          -  Subjects with medical conditions that would prevent study participation\n\n          -  Subjects who are pregnant, nursing, or of child bearing potential and are not on a\n             reliable form of birth control\n\n          -  Subjects enrolled in concurrent studies which could confound the results of this\n             study\n\n          -  Subject is unable or unwilling to participate with study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981590", 
            "org_study_id": "MAPs-breathing"
        }, 
        "intervention": {
            "arm_group_label": "phrenic nerve stimulation", 
            "description": "Intravenously stimulating the phrenic nerve with an EP catheter using high frequency electrical pulses as generated by the model 19039 external neurostimulator.", 
            "intervention_name": "Stimulating the phrenic nerve intravenously using high frequency electrical pulses using an EP catheter connected to external pulse stimulator.", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "breathing, heart failure, sleep apnea", 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "17176"
                }, 
                "name": "Karolinska University Hospital, Solna"
            }, 
            "investigator": {
                "last_name": "Frieder Braunschweig, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Mapping for Acute Transvenous Phrenic Nerve Stimulation Study (MAPS Study)", 
        "overall_contact": {
            "email": "frieder.braunschweig@karolinska.se", 
            "last_name": "Frieder Braunschweig, MD", 
            "phone": "46 8 5177 1629"
        }, 
        "overall_contact_backup": {
            "email": "David.Ersgard@ki.se", 
            "last_name": "David Ersgard", 
            "phone": "46 8 5177 9474"
        }, 
        "overall_official": {
            "affiliation": "Karolinska Institute, department of Cardiology", 
            "last_name": "Frieder Braunschweig, MD, PhD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate the feasibility of transvenous electrical stimulation of the phrenic nerves to elicit inspiration.\nIn more detail \u2022Characterize inspiratory response to changes on stimulation parameters (electrode configuration, amplitude, frequency, and pulse width).\n\u2022Characterize other potential physiologic changes or side effects associated with transvenous nerve stimulation.", 
            "measure": "tidal volume", 
            "safety_issue": "No", 
            "time_frame": "one hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981590"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtronic BRC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic BRC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}